| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.56 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Aim: To evaluate the functional capacity of cardiac amyloidosis patients before starting medication alongside with home-based cardiac rehabilitation program. Methods: The prescription of transthyretin stabilizers requires a patient’s evaluation of the functional capacity. In this study, the functional capacity was assessed by the 6-minute walking test, according to the ATS guidelines. Patients were consecutively recruited for treatment and prior to this, a 6-minute walking teste was performed. Health related quality of life and heart failure symptoms were also evaluated using Minnesota living with heart failure scale and the London Chest Activities of daily living scale. After starting the medication and according to the functional capacity, a home-based cardiac rehabilitation program was also recommended, based on aerobic exercise training like cyclioergometer, walking or using a treadmill, according to patients’ capacity or preferences. Adherence of the rehabilitation program was measured regarding the performance of at least 80% of the sessions prescribed. Patients are contacted twice a month. At one year, a follow-up will be performed. Conclusions: All the selected patients were elected for treatment. Patients have a significant limitation of their functional capacity, associated with moderate quality of life and moderate symptoms. An improvement in these parameters or at least a slowdown in their progression is expected.
Descrição
Palavras-chave
Contexto Educativo
Citação
Delgado, B., & Neto, C. (2025). Functional capacity assessment of cardiac amyloidosis patients before treatment and rehabilitation. 1-1. Poster session presented at Congresso Português de Cardiologia 2025, Porto, Portugal.
Editora
Licença CC
Sem licença CC